Associate Professor of Surgery with tenure
Duke University Medical Center
Durham, North Carolina, United States
Dr. Beasley is an associate professor of surgery with tenure in the division of Surgical Oncology at Duke University with a secondary appointment as an associate professor in the department of medicine. After playing 3 years in the women’s NBA, she began medical school. She obtained her MD (2008) and Masters of Health Science in clinical research (2010) from Duke University School of Medicine. She then completed general surgical residency at Duke University in 2015, during which time she was awarded a traineeship under a long-standing Surgical Oncology T32 grant. She then completed a fellowship in complex surgical oncology at the Ohio State University in 2017. She returned to Duke in 2017 as a faculty member. In 2019, she became co-director of the Duke Melanoma Program.
Dr. Beasley is a surgeon scientist with active involvement in clinical and translational research. Her main clinical and research interests include immunologic aspects of melanoma including oncolytic viral therapy. She is principal investigator of over 10 therapeutic clinical trials in melanoma including novel intratumoral therapies. Her research focuses on the role of innate immunity in the anti-tumor response. She has authored over 100 publications centered on melanoma. She has received multiple internal and external funding including the Society of Surgical Oncology’s Young Investigator Award and an NIH K08 mentored physician scientist award. Most recently she was selected to Duke Medical School’s Alpha Omega Alpha and received the American Society for Clinical Investigation Young Physician-Scientist Award.
P41: Whole Transcriptome Profiling of Patients with In Transit Melanoma
Thursday, March 21, 2024
10:19am – 10:25am ET
Thursday, March 21, 2024
1:57pm – 2:07pm ET
Treatment Options for Recurrent Melanoma- How to Manage Local, Regional and Distant Recurrences?
Friday, March 22, 2024
4:15pm – 4:30pm ET
Saturday, March 23, 2024
8:02am – 8:12am ET